How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent

Open Access

Peer-reviewed

Research Article

Pascal-Henri Keller ,

* E-mail: keller.pascal-henri@wanadoo.fr

Affiliation Department of Psychology, University of Poitiers, 86000, Poitiers, France
⨯
Olivier Grondin,

Affiliation Department of Psychology, University of Bordeaux, 33076 Bordeaux, France
⨯
François Tison,

Affiliations Institute of Neurodegenerative Diseases, University of Bordeaux, 33076 Bordeaux, France, Centre National de la Recherche Scientifique, CNRS UMR5293, 33076 Bordeaux, France
⨯
Francois Gonon

Affiliations Institute of Neurodegenerative Diseases, University of Bordeaux, 33076 Bordeaux, France, Centre National de la Recherche Scientifique, CNRS UMR5293, 33076 Bordeaux, France
⨯

Reader Comments (0)

Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Patients
Is the Subject Area "Patients" applicable to this article?

Thanks for your feedback.
Patient advocacy
Is the Subject Area "Patient advocacy" applicable to this article?

Thanks for your feedback.
Emotions
Is the Subject Area "Emotions" applicable to this article?

Thanks for your feedback.
Huntington disease
Is the Subject Area "Huntington disease" applicable to this article?

Thanks for your feedback.